Skoczylas, S.; Płoszaj, T.; Dróżdż, I.; Moczulska, H.; Serafin, M.; Piekarska, K.; Wojtyczka, O.; Żeżawska, K.; Zmysłowska, A.
Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation. Curr. Oncol. 2026, 33, 10.
https://doi.org/10.3390/curroncol33010010
AMA Style
Skoczylas S, Płoszaj T, Dróżdż I, Moczulska H, Serafin M, Piekarska K, Wojtyczka O, Żeżawska K, Zmysłowska A.
Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation. Current Oncology. 2026; 33(1):10.
https://doi.org/10.3390/curroncol33010010
Chicago/Turabian Style
Skoczylas, Sebastian, Tomasz Płoszaj, Izabela Dróżdż, Hanna Moczulska, Marcin Serafin, Katarzyna Piekarska, Olga Wojtyczka, Karolina Żeżawska, and Agnieszka Zmysłowska.
2026. "Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation" Current Oncology 33, no. 1: 10.
https://doi.org/10.3390/curroncol33010010
APA Style
Skoczylas, S., Płoszaj, T., Dróżdż, I., Moczulska, H., Serafin, M., Piekarska, K., Wojtyczka, O., Żeżawska, K., & Zmysłowska, A.
(2026). Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation. Current Oncology, 33(1), 10.
https://doi.org/10.3390/curroncol33010010
